FDA-Drug2018-01-24Class II
Shiseido Future Solution LX Discovery Set contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022,
SHISEIDO AMERICA INC.
Hazard
GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Sold states
Product was distributed nationwide.
Affected count
N/A
Manufactured in
366 Princeton Hightstown Rd, N/A, East Windsor, NJ, United States
Products
Shiseido Future Solution LX Discovery Set contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022,
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0216-2018Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief